1.Arnold M, Morgan E, Rumgay H, Mafra A, Singh D, Laversanne M, et al. Current and future burden of breast cancer: Global statistics for 2020 and 2040. The Breast. 2022;66:15-23.
2.AlSamhori JF, AlSamhori ARF, Duncan LA, Qalajo A, Alshahwan HF, Al-abbadi M, et al. Artificial intelligence for breast cancer: Implications for diagnosis and management. Journal of Medicine, Surgery, and Public Health. 2024;3:100120.
3.von Fritschen M, Janosz E, Blume C, Jägle U, Keating K, Schneider CK. What’s in a word? Defining “gene therapy medicines”. Molecular therapy Methods & clinical development. 2024;32(4):101348.
4.Maleki Varnosfaderani S, Forouzanfar M. The Role of AI in Hospitals and Clinics: Transforming Healthcare in the 21st Century. Bioengineering (Basel, Switzerland). 2024;11(4).
5.Singh A, Paruthy SB, Belsariya V, Chandra JN, Singh SK, Manivasagam SS, et al. Revolutionizing Breast Healthcare: Harnessing the Role of Artificial Intelligence. Cureus. 2023;15(12):e50203.
6.Malech HL, Garabedian EK, Hsieh MM. Evolution of Gene Therapy, Historical Perspective. Hematology/oncology clinics of North America. 2022;36(4):627-45.
7.Arabi F, Mansouri V, Ahmadbeigi N. Gene therapy clinical trials, where do we go? An overview. Biomedicine & Pharmacotherapy. 2022;153:113324.
8.Bulcha JT, Wang Y, Ma H, Tai PWL, Gao G. Viral vector platforms within the gene therapy landscape. Signal Transduction and Targeted Therapy. 2021;6(1):53.
9.Arun B, Couch FJ, Abraham J, Tung N, Fasching PA. BRCA-mutated breast cancer: the unmet need, challenges and therapeutic benefits of genetic testing. British Journal of Cancer. 2024;131(9):1400-14.
10.Li X, Dai A, Tran R, Wang J. Identifying miRNA biomarkers for breast cancer and ovarian cancer: a text mining perspective. Breast cancer research and treatment. 2023;201(1):5-14.
11.Xu Y, Liu X, Cao X, Huang C, Liu E, Qian S, et al. Artificial intelligence: A powerful paradigm for scientific research. The Innovation. 2021;2(4):100179.
12.Baradaran B, Saedi Ta, Jafarlou V, Shanehbandi D, Maralani M, Othman F. An overview of the history, applications, advantages, disadvantages and prospects of gene therapy. J Biol Regul Homeost Agents. 2016;30:315-21.
13.Vilhekar RS, Rawekar A. Artificial Intelligence in Genetics. Cureus. 2024;16(1):e52035.
14.Dias R, Torkamani A. Artificial intelligence in clinical and genomic diagnostics. Genome Medicine. 2019;11(1):70.
15.Rosenberg SA, Aebersold P, Cornetta K, Kasid A, Morgan RA, Moen R, et al. Gene transfer into humans--immunotherapy of patients with advanced melanoma, using tumor-infiltrating lymphocytes modified by retroviral gene transduction. The New England journal of medicine. 1990;323(9):570-8.
16.Pan X, Veroniaina H, Su N, Sha K, Jiang F, Wu Z, et al. Applications and developments of gene therapy drug delivery systems for genetic diseases. Asian journal of pharmaceutical sciences. 2021;16(6):687-703.
17.Uddin F, Rudin CM, Sen T. CRISPR Gene Therapy: Applications, Limitations, and Implications for the Future. Frontiers in oncology. 2020;10:1387.
18.Du Y, Liu Y, Hu J, Peng X, Liu Z. CRISPR/Cas9 systems: Delivery technologies and biomedical applications. Asian journal of pharmaceutical sciences. 2023;18(6):100854.
19.Butt MH, Zaman M, Ahmad A, Khan R, Mallhi TH, Hasan MM, et al. Appraisal for the Potential of Viral and Nonviral Vectors in Gene Therapy: A Review. Genes. 2022;13(8).
20.Rosenberg S, Aebersold P, Cornetta K, Kasid A, Morgan R, Moen R, et al. Gene Transfer into Humans — Immunotherapy of Patients with Advanced Melanoma, Using Tumor-Infiltrating Lymphocytes Modified by Retroviral Gene Transduction. The New England journal of medicine. 1990;323:570-8.
21.Li H, Yang Y, Hong W, Huang M, Wu M, Zhao X. Applications of genome editing technology in the targeted therapy of human diseases: mechanisms, advances and prospects. Signal Transduction and Targeted Therapy. 2020;5(1):1.
22.Leikas AJ, Ylä-Herttuala S, Hartikainen JEK. Adenoviral Gene Therapy Vectors in Clinical Use—Basic Aspects with a Special Reference to Replication-Competent Adenovirus Formation and Its Impact on Clinical Safety. 2023;24(22):16519.
23.Jiao L, Sun Z, Sun Z, Liu J, Deng G, Wang X. Nanotechnology-based non-viral vectors for gene delivery in cardiovascular diseases. Frontiers in bioengineering and biotechnology. 2024;12:1349077.
24.Wu T, Hu Y, Tang LV. Gene therapy for polygenic or complex diseases. Biomarker Research. 2024;12(1):99.
25.Taghdiri M, Mussolino C. Viral and Non-Viral Systems to Deliver Gene Therapeutics to Clinical Targets. International Journal of Molecular Sciences [Internet]. 2024; 25(13).
26.Lundstrom K. Viral Vectors in Gene Therapy: Where Do We Stand in 2023? Viruses. 2023;15(3).
27.Liu B, Zhou H, Tan L, Siu KTH, Guan X-Y. Exploring treatment options in cancer: tumor treatment strategies. Signal Transduction and Targeted Therapy. 2024;9(1):175.
28.Zhou Y, Tao L, Qiu J, Xu J, Yang X, Zhang Y, et al. Tumor biomarkers for diagnosis, prognosis and targeted therapy. Signal Transduction and Targeted Therapy. 2024;9(1):132.
29.Belete TM. The Current Status of Gene Therapy for the Treatment of Cancer. Biologics : targets & therapy. 2021;15:67-77.
30.Desai I, Thakur S, Pagariya P. Current advances in immunotherapy for cancer. Oral Oncology Reports. 2024;12:100652.
31.    Chehelgerdi M, Chehelgerdi M. The use of RNA-based treatments in the field of cancer immunotherapy. Molecular cancer. 2023;22(1):106.
32.Sellars MC, Wu CJ, Fritsch EF. Cancer vaccines: Building a bridge over troubled waters. Cell. 2022;185(15):2770-88.
33.Jogalekar MP, Rajendran RL, Khan F, Dmello C, Gangadaran P, Ahn BC. CAR T-Cell-Based gene therapy for cancers: new perspectives, challenges, and clinical developments. Frontiers in immunology. 2022;13:925985.
34.Lin D, Shen Y, Liang T. Oncolytic virotherapy: basic principles, recent advances and future directions. Signal Transduction and Targeted Therapy. 2023;8(1):156.
35.Spunde K, Korotkaja K, Zajakina A. Recombinant Viral Vectors for Therapeutic Programming of Tumour Microenvironment: Advantages and Limitations. Biomedicines. 2022;10(9).
36.Tian Y, Xie D, Yang L. Engineering strategies to enhance oncolytic viruses in cancer immunotherapy. Signal Transduct Target Ther. 2022;7(1):117.
37.Wirth T, Ylä-Herttuala S. Gene Therapy Used in Cancer Treatment. Biomedicines. 2014;2(2):149-62.
38.Zafar A, Khan MJ, Abu J, Naeem A. Revolutionizing cancer care strategies: immunotherapy, gene therapy, and molecular targeted therapy. Molecular Biology Reports. 2024;51(1):219.
39.Butt MH, Zaman M, Ahmad A, Khan R, Mallhi TH, Hasan MM, et al. Appraisal for the Potential of Viral and Nonviral Vectors in Gene Therapy: A Review. Genes [Internet]. 2022; 13(8).
40.Khushalani NI, Harrington KJ, Melcher A, Bommareddy PK, Zamarin D. Breaking the barriers in cancer care: The next generation of herpes simplex virus-based oncolytic immunotherapies for cancer treatment. Molecular Therapy - Oncolytics. 2023;31:100729.
41.Sonzogni O, Zak DE, Sasso MS, Lear R, Muntzer A, Zonca M, et al. T-SIGn tumor reengineering therapy and CAR T cells synergize in combination therapy to clear human lung tumor xenografts and lung metastases in NSG mice. Oncoimmunology. 2022;11(1):2029070.
42.Arnold M, Morgan E, Rumgay H, Mafra A, Singh D, Laversanne M, et al. Current and future burden of breast cancer: Global statistics for 2020 and 2040. Breast (Edinburgh, Scotland). 2022;66:15-23.
43.Wang RC, Wang Z. Precision Medicine: Disease Subtyping and Tailored Treatment. Cancers. 2023;15(15).
44.Patel V, Casimiro S, Abreu C, Barroso T, de Sousa RT, Torres S, et al. DNA damage targeted therapy for advanced breast cancer. Exploration of Targeted Anti-tumor Therapy. 2024;5(3):678-98.
45.Zhong L, Li Y, Xiong L, Wang W, Wu M, Yuan T, et al. Small molecules in targeted cancer therapy: advances, challenges, and future perspectives. Signal Transduction and Targeted Therapy. 2021;6(1):201.
46.Irelli A, Patruno LV, Chiatamone Ranieri S, Di Giacomo D, Malatesta S, Alesse E, et al. Role of Breast Cancer Risk Estimation Models to Identify Women Eligible for Genetic Testing and Risk-Reducing Surgery. Biomedicines [Internet]. 2024; 12(4).
47.Larsen MJ, Thomassen M, Gerdes AM, Kruse TA. Hereditary breast cancer: clinical, pathological and molecular characteristics. Breast cancer : basic and clinical research. 2014;8:145-55.
48.Duzkale N, Eyerci N, Oksuzoglu B, Teker T, Kandemir O. Novel BRCA2 pathogenic genotype and breast cancer phenotype discordance in monozygotic triplets. European Journal of Medical Genetics. 2020;63(4):103771.
49.Lim W, Olschwang S, Keller JJ, Westerman AM, Menko FH, Boardman LA, et al. Relative frequency and morphology of cancers in STK11 mutation carriers. Gastroenterology. 2004;126(7):1788-94.
50.Das SK, Menezes ME, Bhatia S, Wang XY, Emdad L, Sarkar D, et al. Gene Therapies for Cancer: Strategies, Challenges and Successes. Journal of cellular physiology. 2015;230(2):259-71.
51.Qi L, Li G, Li P, Wang H, Fang X, He T, et al. Twenty years of Gendicine® rAd-p53 cancer gene therapy: The first-in-class human cancer gene therapy in the era of personalized oncology. Genes & Diseases. 2024;11(4):101155.
52.Wang D, Tai PWL, Gao G. Adeno-associated virus vector as a platform for gene therapy delivery. Nature reviews Drug discovery. 2019;18(5):358-78.
53.Xue C, Greene EC. DNA Repair Pathway Choices in CRISPR-Cas9-Mediated Genome Editing. Trends in genetics : TIG. 2021;37(7):639-56.
54.Bouquet L, Bôle-Richard E, Warda W, Neto Da Rocha M, Trad R, Nicod C, et al. RapaCaspase-9-based suicide gene applied to the safety of IL-1RAP CAR-T cells. Gene Therapy. 2023;30(9):706-13.
55.Casas G, Perche F, Midoux P, Pichon C, Malinge J-M. DNA minicircles as novel STAT3 decoy oligodeoxynucleotides endowed with anticancer activity in triple-negative breast cancer. Molecular Therapy - Nucleic Acids. 2022;29:162-75.
56.Sharma PC, Gupta AJTCR. MicroRNAs: potential biomarkers for diagnosis and prognosis of different cancers. 2020. 2020;9(9):5798-818.
57.Chakrabortty A, Patton DJ, Smith BF, Agarwal P. miRNAs: Potential as Biomarkers and Therapeutic Targets for Cancer. Genes [Internet]. 2023; 14(7).
58.Muñoz JP, Pérez-Moreno P, Pérez Y, Calaf GM. The Role of MicroRNAs in Breast Cancer and the Challenges of Their Clinical Application. Diagnostics (Basel, Switzerland). 2023;13(19).
59.Fan T, Zhang M, Yang J, Zhu Z, Cao W, Dong C. Therapeutic cancer vaccines: advancements, challenges and prospects. Signal Transduction and Targeted Therapy. 2023;8(1):450.
60.Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: a cancer journal for clinicians. 2021;71(3):209-49.
61.Lei S, Zheng R, Zhang S, Wang S, Chen R, Sun K, et al. Global patterns of breast cancer incidence and mortality: A population-based cancer registry data analysis from 2000 to 2020. Cancer communications (London, England). 2021;41(11):1183-94.
62.Choi JE, Kim Z, Park CS, Park EH, Lee SB, Lee SK, et al. Breast Cancer Statistics in Korea, 2019. Journal of breast cancer. 2023;26(3):207-20.
63.Mosele F, Deluche E, Lusque A, Le Bescond L, Filleron T, Pradat Y, et al. Trastuzumab deruxtecan in metastatic breast cancer with variable HER2 expression: the phase 2 DAISY trial. Nature Medicine. 2023;29(8):2110-20.
64.Francies FZ, Hull R, Khanyile R, Dlamini Z. Breast cancer in low-middle income countries: abnormality in splicing and lack of targeted treatment options. American journal of cancer research. 2020;10(5):1568-91.
65.Zheng Y, Ma Y, Xiong Q, Zhu K, Weng N, Zhu Q. The role of artificial intelligence in the development of anticancer therapeutics from natural polyphenols: Current advances and future prospects. Pharmacological Research. 2024;208:107381.
66.Ahmad SF, Han H, Alam MM, Rehmat MK, Irshad M, Arraño-Muñoz M, et al. Impact of artificial intelligence on human loss in decision making, laziness and safety in education. Humanities and Social Sciences Communications. 2023;10(1):311.
67.Bucher A, Blazek ES, Symons CT. How are Machine Learning and Artificial Intelligence Used in Digital Behavior Change Interventions? A Scoping Review. Mayo Clinic Proceedings: Digital Health. 2024;2(3):375-404.
68.Behzadifar M, Behzadifar M, Saran M, Shahabi S, Bakhtiari A, Azari S, et al. The role of Iran’s context for the development of health technology assessment: challenges and solutions. Health Economics Review. 2023;13(1):23.
69.Al Kuwaiti A, Nazer K, Al-Reedy A, Al-Shehri S, Al-Muhanna A, Subbarayalu AV, et al. A Review of the Role of Artificial Intelligence in Healthcare. Journal of personalized medicine. 2023;13(6).
70.Zhang S, Xiao X, Yi Y, Wang X, Zhu L, Shen Y, et al. Tumor initiation and early tumorigenesis: molecular mechanisms and interventional targets. Signal Transduction and Targeted Therapy. 2024;9(1):149.
71.Trivedi PD, Byrne BJ, Corti M. Evolving Horizons: Adenovirus Vectors’ Timeless Influence on Cancer, Gene Therapy and Vaccines. Viruses [Internet]. 2023; 15(12).
72.Cesur-Ergün B, Demir-Dora D. Gene therapy in cancer. 2023;25(11):e3550.
73.Verma C, Pawar VA, Srivastava S, Tyagi A, Kaushik G, Shukla SK, et al. Cancer Vaccines in the Immunotherapy Era: Promise and Potential. Vaccines [Internet]. 2023; 11(12).
74.Bekbolatova M, Mayer J, Ong CW, Toma M. Transformative Potential of AI in Healthcare: Definitions, Applications, and Navigating the Ethical Landscape and Public Perspectives. Healthcare (Basel, Switzerland). 2024;12(2).
75.Liao J, Li X, Gan Y, Han S, Rong P, Wang W, et al. Artificial intelligence assists precision medicine in cancer treatment. Frontiers in oncology. 2022;12:998222.
76.Alowais SA, Alghamdi SS, Alsuhebany N, Alqahtani T, Alshaya AI, Almohareb SN, et al. Revolutionizing healthcare: the role of artificial intelligence in clinical practice. BMC medical education. 2023;23(1):689.
77.Iancu A, Leb I, Prokosch H-U, Rödle W. Machine learning in medication prescription: A systematic review. International Journal of Medical Informatics. 2023;180:105241.
78.Armoundas AA, Narayan SM, Arnett DK, Spector-Bagdady K, Bennett DA, Celi LA, et al. Use of Artificial Intelligence in Improving Outcomes in Heart Disease: A Scientific Statement From the American Heart Association. Circulation. 2024;149(14):e1028-e50.
79.Govindan B, Sabri MA, Hai A, Banat F, Haija MA. A Review of Advanced Multifunctional Magnetic Nanostructures for Cancer Diagnosis and Therapy Integrated into an Artificial Intelligence Approach. Pharmaceutics. 2023;15(3).
80.Elumalai K, Srinivasan S, Shanmugam A. Review of the efficacy of nanoparticle-based drug delivery systems for cancer treatment. Biomedical Technology. 2024;5:109-22.
81.Bi WL, Hosny A, Schabath MB, Giger ML, Birkbak NJ, Mehrtash A, et al. Artificial intelligence in cancer imaging: Clinical challenges and applications. CA: a cancer journal for clinicians. 2019;69(2):127-57.
82.Gavas S, Quazi S, Karpiński TM. Nanoparticles for Cancer Therapy: Current Progress and Challenges. Nanoscale research letters. 2021;16(1):173.
83.Abbasi R, Shineh G, Mobaraki M, Doughty S, Tayebi L. Structural parameters of nanoparticles affecting their toxicity for biomedical applications: a review. Journal of nanoparticle research : an interdisciplinary forum for nanoscale science and technology. 2023;25(3):43.
84.Baliu-Piqué M, Pandiella A, Ocana A. Breast Cancer Heterogeneity and Response to Novel Therapeutics. Cancers. 2020;12(11).
85.Nolan E, Lindeman GJ, Visvader JE. Deciphering breast cancer: from biology to the clinic. Cell. 2023;186(8):1708-28.
86.Bhinder B, Gilvary C, Madhukar NS, Elemento O. Artificial Intelligence in Cancer Research and Precision Medicine. Cancer discovery. 2021;11(4):900-15.
87.Zheng D, He X, Jing J. Overview of Artificial Intelligence in Breast Cancer Medical Imaging. J Clin Med. 2023;12(2).
88.Hussain S, Ali M, Naseem U, Nezhadmoghadam F, Jatoi MA, Gulliver TA, et al. Breast cancer risk prediction using machine learning: a systematic review. Frontiers in oncology. 2024;14:1343627.
89.Conte L, Rizzo E, Civino E, Tarantino P, De Nunzio G, De Matteis E. Enhancing Breast Cancer Risk Prediction with Machine Learning: Integrating BMI, Smoking Habits, Hormonal Dynamics, and BRCA Gene Mutations—A Game-Changer Compared to Traditional Statistical Models? Applied Sciences [Internet]. 2024; 14(18).
90.Zhu L, Jiang M, Wang H, Sun H, Zhu J, Zhao W, et al. A narrative review of tumor heterogeneity and challenges to tumor drug therapy. Annals of translational medicine. 2021;9(16):1351.
91.Salk JJ, Fox EJ, Loeb LA. Mutational heterogeneity in human cancers: origin and consequences. Annual review of pathology. 2010;5:51-75.
92.Dixit S, Kumar A, Srinivasan K, Vincent P, Ramu Krishnan N. Advancing genome editing with artificial intelligence: opportunities, challenges, and future directions. Frontiers in bioengineering and biotechnology. 2023;11:1335901.
93.Odhiambo P, Okello H, Wakaanya A, Wekesa C, Okoth P. Mutational signatures for breast cancer diagnosis using artificial intelligence. Journal of the Egyptian National Cancer Institute. 2023;35(1):14.
94.Johnson KB, Wei WQ, Weeraratne D, Frisse ME, Misulis K, Rhee K, et al. Precision Medicine, AI, and the Future of Personalized Health Care. Clinical and translational science. 2021;14(1):86-93.
95.Xiong Z, Liu K, Liu S, Feng J, Wang J, Feng Z, et al. Precision HER2: a comprehensive AI system for accurate and consistent evaluation of HER2 expression in invasive breast Cancer. BMC cancer. 2024;24(1):1204.
96.Bakoglu N, Cesmecioglu E, Sakamoto H, Yoshida M, Ohnishi T, Lee S-Y, et al. Artificial intelligence-based automated determination in breast and colon cancer and distinction between atypical and typical mitosis using a cloud-based platform. 2024;30.
97.Uchikov P, Khalid U, Dedaj-Salad GH, Ghale D, Rajadurai H, Kraeva M, et al. Artificial Intelligence in Breast Cancer Diagnosis and Treatment: Advances in Imaging, Pathology, and Personalized Care. Life (Basel, Switzerland). 2024;14(11).
98.Sohrabei S, Moghaddasi H, Hosseini A, Ehsanzadeh SJ. Investigating the effects of artificial intelligence on the personalization of breast cancer management: a systematic study. BMC cancer. 2024;24(1):852.
99.    Lynch SM, Heeran AB, Burke C, Lynam-Lennon N, Eustace AJ, Dean K, et al. Precision Oncology, Artificial Intelligence, and Novel Therapeutic Advancements in the Diagnosis, Prevention, and Treatment of Cancer: Highlights from the 59th Irish Association for Cancer Research (IACR) Annual Conference. Cancers [Internet]. 2024; 16(11).
100.Yi M, Li T, Niu M, Zhang H, Wu Y, Wu K, et al. Targeting cytokine and chemokine signaling pathways for cancer therapy. Signal Transduction and Targeted Therapy. 2024;9(1):176.
101.Page MJ, Moher D, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews. BMJ (Clinical research ed). 2021;372:n160.
102.Uchikov P, Khalid U, Dedaj-Salad GH, Ghale D, Rajadurai H, Kraeva M, et al. Artificial Intelligence in Breast Cancer Diagnosis and Treatment: Advances in Imaging, Pathology, and Personalized Care. Life [Internet]. 2024; 14(11).
103.Zhu Z, Jiang L, Ding X. Advancing Breast Cancer Heterogeneity Analysis: Insights from Genomics, Transcriptomics and Proteomics at Bulk and Single-Cell Levels. Cancers. 2023;15(16).
104.Mennella C, Maniscalco U, De Pietro G, Esposito M. Ethical and regulatory challenges of AI technologies in healthcare: A narrative review. Heliyon. 2024;10(4):e26297.
105.Yang S, Kar S. Application of artificial intelligence and machine learning in early detection of adverse drug reactions (ADRs) and drug-induced toxicity. Artificial Intelligence Chemistry. 2023;1(2):100011.
106.You Y, Lai X, Pan Y, Zheng H, Vera J, Liu S, et al. Artificial intelligence in cancer target identification and drug discovery. Signal Transduction and Targeted Therapy. 2022;7(1):156.
107.Karalis VD. The Integration of Artificial Intelligence into Clinical Practice. Applied Biosciences [Internet]. 2024; 3(1):[14-44 pp.].
108.Khosravi M, Zare Z, Mojtabaeian SM, Izadi R. Artificial Intelligence and Decision-Making in Healthcare: A Thematic Analysis of a Systematic Review of Reviews. Health services research and managerial epidemiology. 2024;11:23333928241234863.
109.Ahmed MI, Spooner B, Isherwood J, Lane M, Orrock E, Dennison A. A Systematic Review of the Barriers to the Implementation of Artificial Intelligence in Healthcare. Cureus. 2023;15(10):e46454.
110.Kann BH, Hosny A, Aerts HJWL. Artificial intelligence for clinical oncology. Cancer Cell. 2021;39(7):916-27.
111.Huanbutta K, Burapapadh K, Kraisit P, Sriamornsak P, Ganokratanaa T, Suwanpitak K, et al. Artificial intelligence-driven pharmaceutical industry: A paradigm shift in drug discovery, formulation development, manufacturing, quality control, and post-market surveillance. European Journal of Pharmaceutical Sciences. 2024;203:106938.
112.Ektefaie Y, Shen A, Bykova D, Marin M, Zitnik M, Farhat M. Evaluating generalizability of artificial intelligence models for molecular datasets. 2024:2024.02.25.581982.
113.Norori N, Hu Q, Aellen FM, Faraci FD, Tzovara A. Addressing bias in big data and AI for health care: A call for open science. Patterns (New York, NY). 2021;2(10):100347.
114.Novelli C, Casolari F, Hacker P, Spedicato G, Floridi L. Generative AI in EU law: Liability, privacy, intellectual property, and cybersecurity. Computer Law & Security Review. 2024;55:106066.
115.Chuan C-H, Sun R, Tian S, Tsai W-HS. EXplainable Artificial Intelligence (XAI) for facilitating recognition of algorithmic bias: An experiment from imposed users’ perspectives. Telematics and Informatics. 2024;91:102135.
116.Ghassemi M, Oakden-Rayner L, Beam AL. The false hope of current approaches to explainable artificial intelligence in health care. The Lancet Digital health. 2021;3(11):e745-e50.
117.Ali O, Abdelbaki W, Shrestha A, Elbasi E, Alryalat MAA, Dwivedi YK. A systematic literature review of artificial intelligence in the healthcare sector: Benefits, challenges, methodologies, and functionalities. Journal of Innovation & Knowledge. 2023;8(1):100333.
118.Alowais SA, Alghamdi SS, Alsuhebany N, Alqahtani T, Alshaya AI, Almohareb SN, et al. Revolutionizing healthcare: the role of artificial intelligence in clinical practice. BMC medical education. 2023;23(1):689.